Mirae Asset Global Etfs Holdings Ltd. Edgewise Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 39,718 shares of EWTX stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,718
Previous 29,286
35.62%
Holding current value
$1.07 Million
Previous $527,000
101.14%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EWTX
# of Institutions
191Shares Held
100MCall Options Held
2.17MPut Options Held
410K-
Orbimed Advisors LLC San Diego, CA15MShares$406 Million9.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$241 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$163 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$158 Million1.67% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$150 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.71B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...